EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Atrial Fibrillation Burden on a 14-Day ECG Monitor

Daniel E Singer, Steven J Atlas, Alan S Go, Steven A Lubitz, David D McManus, Rowena J Dolor, Ranee Chatterjee, Michael B Rothberg, David R Rushlow, Lori A Crosson, Ronald S Aronson, Donna Mills und 4 weitere

JACC: Clinical Electrophysiology · 2025

DOI: 10.1016/j.jacep.2024.08.010 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift JACC: Clinical Electrophysiology, 2025. Verfasst von Daniel E Singer und 15 weiteren Autor:innen. Beteiligte Einrichtung: Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA…. Hauptthemen laut MEDLINE: Atrial Fibrillation, Electrocardiography, Ambulatory, Electrocardiography. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Bristol-Myers Squibb Co.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: The "burden" of atrial fibrillation (AF) detected by screening likely influences stroke risk, but the distribution of burden is not well described. OBJECTIVES: This study aims to determine the frequency of AF and the distribution of AF burden found when screening individuals ≥70 years of age with a 14-day electrocardiograph monitor. METHODS: This is a cohort study of the screening arm of a randomized AF screening trial among those ≥70 years of age without a prior AF diagnosis (between 2019 and 2021). Screening was performed with a 14-day continuous electrocardiogram patch monitor. RESULTS: Analyzable patches were returned by 5,684 (95%) of screening arm participants; the median age was 75 years (Q1-Q3: 72-78 years), 57% were female, and the median CHA2DS2-VASc score was 3 (Q1-Q3: 2-4). AF was detected in 252 participants (4.4%); 29 (0.5%) patients had continuous AF and 223 (3.9%) had paroxysmal AF. Among those with paroxysmal AF, the average indices of AF burden were of low magnitude with right-skewed distributions. The median percent time in AF was 0.46% (Q1-Q3: 0.02%-2.48%), or 75 (Q1-Q3: 3-454) minutes, and the median longest episode was 38 (Q1-Q3: 2-245) minutes. The upper quartile threshold of 2.48% time in AF corresponded to 7.6 hours. Age >80 years was associated with screen-detected AF in our multivariable model (OR: 1.46; 95% CI: 1.06-2.02). CONCLUSIONS: Most AF detected in these older patients was very low burden. However, one-quarter of those with AF had multiple hours of AF, raising concern about stroke risk. These findings have implications for targeting populations for AF screening trials and for responding to heart rhythm alerts from mobile devices (GUARD-AF [A Study to Determine if Identification of Undiagnosed Atrial Fibrillation in People at least 70 Years of Age Reduces the Risk of Stroke]; NCT04126486).

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationElectrocardiography, AmbulatoryElectrocardiographyHumansFemaleAgedMaleMass ScreeningAged, 80 and overCohort Studies

Stichwörter der Autor:innen

atrial fibrillation burdenscreeningsubclinical atrial fibrillation

Autor:innen und Institutionen

  • Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA. Electronic address: desinger@mgh.harvard.edu.
  • Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts, USA; Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Research, Kaiser Permanente Northern California, Oakland, California, USA.
  • Harvard Medical School, Boston, Massachusetts, USA; Demoulas Center for Cardiac Arrhythmias, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medicine, University of Massachusetts Chan Medical School, Worcester, Massachusetts, USA.
  • Division of General Internal Medicine, Department of Medicine, Duke University School of Medicine, Durham, North Carolina, USA.

Förderung

  • Bristol-Myers Squibb Co

Zitieren

APA

Singer, D. E., Atlas, S. J., Go, A. S., Lubitz, S. A., McManus, D. D., Dolor, R. J., Chatterjee, R., Rothberg, M. B., Rushlow, D. R., Crosson, L. A., Aronson, R. S., Mills, D., Patlakh, M., Gallup, D., O'Brien, E. C., & Lopes, R. D. (2025). Atrial Fibrillation Burden on a 14-Day ECG Monitor. JACC: Clinical Electrophysiology. https://doi.org/10.1016/j.jacep.2024.08.010

Vancouver

Singer DE, Atlas SJ, Go AS, Lubitz SA, McManus DD, Dolor RJ, et al. Atrial Fibrillation Burden on a 14-Day ECG Monitor. JACC: Clinical Electrophysiology. 2025. doi:10.1016/j.jacep.2024.08.010

BibTeX
@article{Singer2025,
  author = {Singer, Daniel E and Atlas, Steven J and Go, Alan S and Lubitz, Steven A and McManus, David D and Dolor, Rowena J and Chatterjee, Ranee and Rothberg, Michael B and Rushlow, David R and Crosson, Lori A and Aronson, Ronald S and Mills, Donna and Patlakh, Michael and Gallup, Dianne and O'Brien, Emily C and Lopes, Renato D},
  title = {Atrial Fibrillation Burden on a 14-Day ECG Monitor},
  journal = {JACC: Clinical Electrophysiology},
  year = {2025},
  doi = {10.1016/j.jacep.2024.08.010}
}
Kostenlos starten →